These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3344933)

  • 21. An asthmatic child with allergic bronchopulmonary aspergillosis (ABPA).
    Özdemir Ö
    Turk J Pediatr; 2018; 60(4):446-452. PubMed ID: 30859774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergic bronchopulmonary aspergillosis. An increasingly common disorder among asthmatic patients.
    Richeson RB; Stander PE
    Postgrad Med; 1990 Sep; 88(3):217-9, 222, 224. PubMed ID: 2204899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab.
    Lin RY; Sethi S; Bhargave GA
    J Asthma; 2010 Oct; 47(8):942-5. PubMed ID: 20831464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
    Emiralioglu N; Dogru D; Tugcu GD; Yalcin E; Kiper N; Ozcelik U
    Ann Pharmacother; 2016 Mar; 50(3):188-93. PubMed ID: 26699090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes.
    Agarwal R; Garg M; Aggarwal AN; Saikia B; Gupta D; Chakrabarti A
    Respir Med; 2012 Jul; 106(7):942-7. PubMed ID: 22445696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    Chishimba L; Niven RM; Cooley J; Denning DW
    J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?
    Laoudi Y; Paolini JB; Grimfed A; Just J
    Eur Respir J; 2008 Apr; 31(4):908-9. PubMed ID: 18378789
    [No Abstract]   [Full Text] [Related]  

  • 29. Allergic bronchopulmonary aspergillosis: it's here in South Carolina.
    Imbeau SA
    J S C Med Assoc; 2006 Jun; 102(5):126-8. PubMed ID: 17315519
    [No Abstract]   [Full Text] [Related]  

  • 30. Coexisting atopic conditions influence the likelihood of allergic bronchopulmonary aspergillosis in asthma.
    Tay TR; Bosco J; Gillman A; Aumann H; Stirling R; O'Hehir R; Hew M
    Ann Allergy Asthma Immunol; 2016 Jul; 117(1):29-32.e1. PubMed ID: 27234940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).
    Chishimba L; Langridge P; Powell G; Niven RM; Denning DW
    J Asthma; 2015 Apr; 52(3):289-95. PubMed ID: 25158109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis: a clinical and serologic evaluation.
    Kumar R
    Chest; 2003 Sep; 124(3):890-2. PubMed ID: 12970013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis.
    Salez F; Brichet A; Desurmont S; Grosbois JM; Wallaert B; Tonnel AB
    Chest; 1999 Dec; 116(6):1665-8. PubMed ID: 10593792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular-based allergy diagnosis of allergic bronchopulmonary aspergillosis in Aspergillus fumigatus-sensitized Japanese patients.
    Tanimoto H; Fukutomi Y; Yasueda H; Takeuchi Y; Saito A; Watai K; Sekiya K; Tsuburai T; Asano K; Taniguchi M; Akiyama K
    Clin Exp Allergy; 2015 Dec; 45(12):1790-800. PubMed ID: 26118958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of allergic bronchopulmonary aspergillosis.
    Wang JL; Patterson R; Roberts M; Ghory AC
    Am Rev Respir Dis; 1979 Jul; 120(1):87-92. PubMed ID: 464387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allergic bronchopulmonary aspergillosis.
    Greenberger PA
    J Allergy Clin Immunol; 2002 Nov; 110(5):685-92. PubMed ID: 12417875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis.
    Agarwal R; Dua D; Choudhary H; Aggarwal AN; Sehgal IS; Dhooria S; Garg M; Behera D; Chakrabarti A
    Mycoses; 2017 Jan; 60(1):33-39. PubMed ID: 27523578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis.
    Agarwal R; Gupta D; Aggarwal AN; Saxena AK; Saikia B; Chakrabarti A; Jindal SK
    Respir Med; 2010 Feb; 104(2):204-10. PubMed ID: 19800210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of budesonide in severe asthmatics aged 1-3 years.
    Connett GJ; Warde C; Wooler E; Lenney W
    Arch Dis Child; 1993 Sep; 69(3):351-5. PubMed ID: 8215545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic bronchopulmonary aspergillosis.
    Vaughan LM
    Clin Pharm; 1993 Jan; 12(1):24-33. PubMed ID: 8428430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.